Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MTRY Stock Summary
In the News
MTRY Financial details
Company Rating
Sell
Market Cap
48.3M
Income
-1.03M
Revenue
0
Book val./share
3.97
Cash/share
0.11
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-31.05
Forward P/E
-
PEG
-3.72
P/S
-
P/B
1.65
P/C
101.27
P/FCF
-49.23
Quick Ratio
0.18
Current Ratio
0.18
Debt / Equity
0.1
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
1.58
EPS this Y
300%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-0.32%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
34.58%
Inst Trans
0.74%
ROA
-5%
ROE
-5%
ROC
-0.1%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
4.34M
Shs Float
1.1M
-
-
-
-
Target Price
-
52W Range
10.21-12.0
52W High
-7.17%
52W Low
+11.4%
RSI
42
Rel Volume
1.23
Avg Volume
3.45K
Volume
4.24K
Perf Week
0%
Perf Month
-1.07%
Perf Quarter
-
Perf Half Y
-1.33%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0.07%
Prev Close
0%
Price
11.14
Change
0%
MTRY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|
2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | |
Net income per share | 0 | -0.11 | -0.44 | |
Operating cash flow per share | 0 | -0.18 | -0.35 | |
Free cash flow per share | 0 | -0.18 | -0.35 | |
Cash per share | 10 | 0.1 | 7.37 | |
Book value per share | 9.6 | 21.85 | 6.87 | |
Tangible book value per share | 9.6 | 21.85 | 6.87 | |
Share holders equity per share | 9.6 | 21.85 | 6.87 | |
Interest debt per share | 0 | 0 | -0.31 | |
Market cap | 24.75K | 52.78M | 30.19M | |
Enterprise value | -250 | 52.26M | 30.04M | |
P/E ratio | -10.31K | -90.86 | -23.7 | |
Price to sales ratio | 0 | 0 | 0 | |
POCF ratio | 0 | -56.16 | -30.07 | |
PFCF ratio | 0 | -56.16 | -30.07 | |
P/B Ratio | 1.03 | 0.45 | 1.53 | |
PTB ratio | 1.03 | 0.45 | 1.53 | |
EV to sales | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | -113.58 | -14.73 | |
EV to operating cash flow | 0 | -55.62 | -29.92 | |
EV to free cash flow | 0 | -55.62 | -29.92 | |
Earnings yield | 0 | -0.01 | -0.04 | |
Free cash flow yield | 0 | -0.02 | -0.03 | |
Debt to equity | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 1.11 | 0.07 | |
Current ratio | 25 | 3.25 | 0.23 | |
Interest coverage | 0 | 0 | 2.31 | |
Income quality | 0 | 1.61 | 0.79 | |
Dividend Yield | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | |
Graham number | 0.46 | 7.3 | 8.27 | |
ROIC | 0 | 0 | -0.11 | |
Return on tangible assets | 0 | 0 | -0.06 | |
Graham Net | 9.6 | 0.05 | 6.78 | |
Working capital | 24K | 643.92K | -1.29M | |
Tangible asset value | 24K | 117.07M | 19.74M | |
Net current asset value | 24K | 643.92K | -1.29M | |
Invested capital | 0 | 0 | 0 | |
Average receivables | 0 | 15K | 15K | |
Average payables | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | |
ROE | 0 | 0 | -0.06 | |
Capex per share | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.03 | -0.11 | -0.03 | -0.03 | |
Operating cash flow per share | -0.01 | -0.01 | -0.13 | -0.03 | -0.07 | |
Free cash flow per share | -0.01 | -0.01 | -0.13 | -0.03 | -0.07 | |
Cash per share | 8.08 | 8.23 | 0.05 | 4.44 | 0.11 | |
Book value per share | 8.11 | 1.41 | 6.87 | 4 | 3.97 | |
Tangible book value per share | 8.11 | 1.41 | 6.87 | 4 | 3.97 | |
Share holders equity per share | 8.11 | 1.41 | 6.87 | 4 | 3.97 | |
Interest debt per share | -0.01 | -0.04 | -0.07 | 0.19 | 0.39 | |
Market cap | 144.04M | 143.27M | 30.19M | 52.27M | 53.45M | |
Enterprise value | 144.03M | 142.73M | 30.04M | 53.2M | 54.83M | |
P/E ratio | -190.66 | -85.18 | -24.57 | -85.83 | -88.2 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -853.66 | -1.18K | -77.99 | -394.42 | -157.08 | |
PFCF ratio | -853.66 | -1.18K | -77.99 | -394.42 | -157.08 | |
P/B Ratio | 1.24 | 7.15 | 1.53 | 2.67 | 2.75 | |
PTB ratio | 1.24 | 7.15 | 1.53 | 2.67 | 2.75 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -420.13 | -165.22 | -64.86 | -156.88 | -149.96 | |
EV to operating cash flow | -853.63 | -1.18K | -77.62 | -401.4 | -161.14 | |
EV to free cash flow | -853.63 | -1.18K | -77.62 | -401.4 | -161.14 | |
Earnings yield | 0 | 0 | -0.01 | 0 | 0 | |
Free cash flow yield | 0 | 0 | -0.01 | 0 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0.06 | 0.1 | |
Debt to assets | 0 | 0 | 0 | 0.05 | 0.09 | |
Net debt to EBITDA | 0.01 | 0.63 | 0.31 | -2.73 | -3.77 | |
Current ratio | 1.38 | 0.01 | 0.23 | 0.17 | 0.18 | |
Interest coverage | 2.19 | 1.65 | 2.46 | 1.51 | 0 | |
Income quality | 0.89 | 0.29 | 1.26 | 0.87 | 2.25 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.55 | 0.97 | 4.06 | 1.67 | 1.66 | |
ROIC | 0 | -0.05 | -0.03 | -0.02 | -0.02 | |
Return on tangible assets | 0 | 0 | -0.01 | -0.01 | -0.01 | |
Graham Net | 8.06 | 1.36 | -0.53 | 3.97 | -0.5 | |
Working capital | 110.71K | -96.5M | -1.29M | -1.9M | -2.43M | |
Tangible asset value | 116.52M | 20.05M | 19.74M | 19.59M | 19.44M | |
Net current asset value | 110.71K | -96.5M | -1.29M | -1.9M | -2.43M | |
Invested capital | 0 | 0 | 0 | 0.06 | 0.1 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.02 | -0.02 | -0.01 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MTRY Frequently Asked Questions
What is Monterey Bio Acquisition Corporation stock symbol ?
Monterey Bio Acquisition Corporation is a US stock , located in New york of Ny and trading under the symbol MTRY
What is Monterey Bio Acquisition Corporation stock quote today ?
Monterey Bio Acquisition Corporation stock price is $11.14 today.
Is Monterey Bio Acquisition Corporation stock public?
Yes, Monterey Bio Acquisition Corporation is a publicly traded company.